Peter W. Hellings

47.4k total citations · 7 hit papers
320 papers, 13.1k citations indexed

About

Peter W. Hellings is a scholar working on Immunology and Allergy, Physiology and Otorhinolaryngology. According to data from OpenAlex, Peter W. Hellings has authored 320 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Immunology and Allergy, 166 papers in Physiology and 118 papers in Otorhinolaryngology. Recurrent topics in Peter W. Hellings's work include Allergic Rhinitis and Sensitization (197 papers), Asthma and respiratory diseases (164 papers) and Sinusitis and nasal conditions (118 papers). Peter W. Hellings is often cited by papers focused on Allergic Rhinitis and Sensitization (197 papers), Asthma and respiratory diseases (164 papers) and Sinusitis and nasal conditions (118 papers). Peter W. Hellings collaborates with scholars based in Belgium, Netherlands and United States. Peter W. Hellings's co-authors include Claus Bachert, Jan Ceuppens, Brecht Steelant, Philippe Gevaert, Wytske J. Fokkens, Glenis Scadding, Mark Jorissen, Sven Seys, Dominique Bullens and Joaquim Mullol and has published in prestigious journals such as The Lancet, JAMA and Nature Communications.

In The Last Decade

Peter W. Hellings

302 papers receiving 12.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Allergic rhinitis

2011 617 citations Peter W. Hellings, Glenis Scadding et al. profile →
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis

2016 553 citations Claus Bachert, Leda Mannent et al. profile →
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

2012 527 citations Philippe Gevaert, Lien Calus et al. profile →
Executive Summary of EPOS 2020 Including Integrated Care Pathways

2020 263 citations Wytske J. Fokkens, V J Lund et al. Rhinology Journal profile →
Epithelial barriers in allergy and asthma

2020 242 citations Peter W. Hellings, Brecht Steelant profile →
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management

2020 213 citations Claus Bachert, Martin Wagenmann et al. profile →
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023

2023 152 citations Diego M. Conti, Philippe Gevaert et al. Rhinology Journal profile →

Peers

Countries citing papers authored by Peter W. Hellings

Since Specialization

Citations

This map shows the geographic impact of Peter W. Hellings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Hellings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Hellings more than expected).

Fields of papers citing papers by Peter W. Hellings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Hellings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Hellings. The network helps show where Peter W. Hellings may publish in the future.

Co-authorship network of co-authors of Peter W. Hellings

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Hellings. A scholar is included among the top collaborators of Peter W. Hellings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Hellings. Peter W. Hellings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Remission in chronic rhinosinusitis with nasal polyps 2025 ·Rhinology Journal ·Peter W. Hellings, Eugenio De Corso, Vibeke Backer, Manuel Bernal‐Sprekelsen, Yi Tao Chan, Diego M. Conti, Marjolein Cornet, W. J. Fokkens, Philippe Gevaert, (unknown), Claire Hopkins, Basile N. Landis, Susanne Lau, Stephanie J. Lee, V J Lund, J Mullol, Albert J. Peters, Sven Schneider, Brent A. Senior	1
2	Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach 2025 ·Clinical and Translational Allergy ·Oliver Pfaar, Anju T. Peters, Camille Taillé, (unknown), Jared Silver, Robert Chan, Peter W. Hellings	3
3	Algorithm for the Management of Primary Diffuse Chronic Rhinosinusitis 2024 ·Allergy ·Wytske J. Fokkens, Eugenio De Corso, Peter W. Hellings, Richard J. Harvey, Claire Hopkins, Sietze Reitsma	1
4	Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps 2024 ·Current Allergy and Asthma Reports ·Eugenio De Corso, Peter W. Hellings, Wytske J. Fokkens, Ludger Klimek, Anju T. Peters, Glenis Scadding, Martin Desrosiers, Stella E. Lee, Joaquim Mullol	3
5	Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up 2023 ·International Forum of Allergy & Rhinology ·Martin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, Peter W. Hellings, Joseph K. Han, Anju T. Peters, Jared Silver, Steven G. Smith, (unknown), Ana R. Sousa, Robert Chan, Philippe Gevaert, (unknown)	19
6	Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps 2023 ·Otolaryngology ·Claire Hopkins, Joaquim Mullol, Asif Khan, Stella E. Lee, Martin Wagenmann, Peter W. Hellings, Wytske J. Fokkens, Jérôme Msihid, (unknown), Siddhesh Kamat, (unknown), Amr Radwan, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe	4
7	Tackling nasal symptoms in athletes: Moving towards personalized medicine 2021 ·Allergy ·Valérie Hox, (unknown), Dominique Bullens, Mariana Couto, Daniël Langer, Peter W. Hellings, Caroline Huart, Philippe Rombaux, Sven Seys, Pavol Šurda, Abigail Walker, Brecht Steelant	5
8	Lacticaseibacillus casei AMBR2 Restores Airway Epithelial Integrity in Chronic Rhinosinusitis With Nasal Polyps 2021 ·Allergy Asthma and Immunology Research ·Katleen Martens, Ilke De Boeck, (unknown), Filip Kiekens, Ricard Farré, Olivier M. Vanderveken, Sven Seys, Sarah Lebeer, Peter W. Hellings, Brecht Steelant	11
9	Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis 2019 ·Allergy ·Claus Bachert, Peter W. Hellings, Joaquim Mullol, Daniel L. Hamilos, Philippe Gevaert, Robert M. Naclerio, Vijay N. Joish, Jingdong Chao, Leda Mannent, Nikhil Amin, Adeline Abbé, (unknown), Chunpeng Fan, Gianluca Pirozzi, Neil M.H. Graham, Puneet Mahajan, Heribert Staudinger, Asif Khan	74
10	Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document 2018 ·Allergy ·Ioana Agache, Rachel L. Miller, James E. Gern, Peter W. Hellings, Marek Jutel, Antonella Muraro, Wanda Phipatanakul, Santiago Quirce, David B. Peden	67
11	The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps 2017 ·Rhinology Journal ·(unknown), (unknown), (unknown), Gabriële Holtappels, Peter W. Hellings, Thibaut Van Zele, (unknown), (unknown)	38
12	Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease 2017 ·Rhinology Journal ·Brecht Steelant, (unknown), Guy E. Boeckxstaens, Cezmi A. Akdiş, Jan Ceuppens, Peter W. Hellings	33
13	The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps 2017 ·Rhinology Journal ·(unknown), Lara Derycke, Lien Calus, Gabriële Holtappels, Peter W. Hellings, Thibaut Van Zele, Claus Bachert, Philippe Gevaert	27
14	Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease 2016 ·Rhinology Journal ·Brecht Steelant, Sven Seys, (unknown), Cezmi A. Akdiş, Jan Ceuppens, Peter W. Hellings	61
15	Rhinology in the forefront of European political attention 2015 ·Rhinology Journal ·(unknown), Peter W. Hellings	1
16	MP29-02* provides a rapid clinically-meaningful response for moderate/severe seasonal allergic rhinitis patients : a meta-analysis 2015 ·Allergy ·Jean Bousquet, Claus Bachert, Joaquim Mullol, (unknown), Wytske J. Fokkens, Peter W. Hellings, Nikolaos G. Papadopoulos, (unknown)	1
17	Improvement of nasal breathing and patient satisfaction by the endonasal dilator Airmax® 2014 ·Rhinology Journal ·Peter W. Hellings, Gilbert J. Nolst Trenité	3
18	Negative impact of occupational exposure on surgical outcome in patients with rhinosinusitis 2012 ·Allergy ·Valérie Hox, (unknown), Hans Scheers, Erwin Adams, (unknown), Mark Jorissen, Peter Hoet, Jeroen Vanoirbeek, Benoît Nemery, Peter W. Hellings	40
19	Up-date on neuro-immune mechanisms involved in allergic and non-allergic rhinitis 2012 ·Rhinology Journal ·Laura Van Gerven, Guy E. Boeckxstaens, Peter W. Hellings	39
20	IL-12-independent down-regulation of allergic airway inflammation in mice by agonistic anti-CD40 mAb 2002 ·Allergy ·Peter W. Hellings, Ahmad Kasran, Lut Overbergh, Chantal Mathieu, Louis Boon, Hubertine Heremans, Patrick Matthys, Jan Ceuppens	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact